Skip to main content

Duchenne Muscular Dystrophy clinical trials at UC Irvine

2 research studies open to eligible people

Showing trials for
  • EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

    open to eligible males ages 12-50

    A study of sevasemten (EDG-5506) in Becker muscular dystrophy (known as CANYON) and pivotal cohort (known as GRAND CANYON). The EDG-5506-201 CANYON study was expanded to include an additional 120 adult participants in a cohort called GRAND CANYON, that is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of sevasemten in adults with Becker. CANYON is fully enrolled; GRAND CANYON is currently enrolling.

    Orange, California and other locations

  • Defining Endpoints in Becker Muscular Dystrophy

    open to eligible males ages 6 years and up

    This is a 24-month, observational study of 50 participants with Becker muscular dystrophy (BMD)

    Orange, California and other locations

Our lead scientists for Duchenne Muscular Dystrophy research studies include .

Last updated: